Use access key #2 to skip to page content.
$17.86 -0.08 (-0.45%)
7/23/2008 4:07 PM

Par Pharmaceutical Companies, Inc. (PRX)

CAPS Rating:
***

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating PRX

Add Stock to Watchlist

What the Community Thinks

Total Members

108 Outperforms
18 Underperforms
 

All-Stars

44 Outperforms
5 Underperforms
 

Wall Street

2 Outperforms
2 Underperforms
 

Members bullish on PRX are also bullish on:

Members bearish on PRX are also bearish on:

Ticker Tags

Small Cap (1922), Drugs - Generic (14)
Suggest a tag

Par Pharmaceutical Companies, Inc. At A Glance

Current Price: $17.86
Last Trade Time: 7/23/2008 4:07 PM
Open: $17.87
Previous Close: $17.94
Daily Range: $17.56 - $18.03
52-Week Range: $15.00 - $24.73
Volume: 476,836
Market Cap: $619.50M
P/E Ratio: 49.83
Compare Our Special Broker Offers!

Stock Trends

PRX VS S&P 500 (SPY)

PRX 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

1

Par Pharmaceutical Companies, Inc. (PRX)

Avatar 00746angel (< 20) Submitted: 2/18/07 8:28 PM

shipping out new approved drugs
as fast as they can produce them
pipe lines need to be filled
also esclusive rights for six months

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Par Pharmaceutical Companies, Inc. (PRX)

Avatar wolfhounds (63.76) Submitted: 1/02/08 11:56 AM

2007 had 4 compounds in stage 3. Down to 2, one with at least another year of clinical trials.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 18 :   1 2 3 4 Next »

Recs

0

 (PRX)

Avatar slimpickins2 (41.11) Submitted: 4/17/08 1:22 PM : Outperform Start Price: $17.96 PRX Score: 5.27

Another pharma play, good price level

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PRX)

Avatar tikiskis (86.09) Submitted: 2/05/08 3:19 PM : Outperform Start Price: $19.48 PRX Score: -3.76

Two words will boost this company: baby boomers. That combined with a faling health care system that intentionally plunges people into poverty will make discount drugs the place to be.





Granted, the above is only a justification for why this niche INDUSTRY will be good in the long term. There are still legitimate concerns about the financials on this company. However, given its place in foreign markets and the risk factor for any pharma company (especially one undercutting the majors), this is a bet that I believe will pay off.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (PRX)

Avatar wolfhounds (63.76) Submitted: 1/02/08 11:56 AM : Underperform Start Price: $23.75 PRX Score: 13.23

2007 had 4 compounds in stage 3. Down to 2, one with at least another year of clinical trials.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PRX)

Avatar Pirate38 (56.76) Submitted: 12/18/07 3:43 PM : Underperform Start Price: $21.05 PRX Score: 2.80

This company's income statement shows no profit and dwindling sales. There is time for a stock correction.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PRX)

Avatar SteadySaber (74.19) Submitted: 9/28/07 12:35 PM : Underperform Start Price: $17.07 PRX Score: -20.58

No growth for 2008. Street hates that.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 18 :   1 2 3 4 Next »

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJPMorgan 90.52 03/04/08 03/04/08 Underperform NS $18.60-3.98%-3.04%+0.94
TrackSoros 89.82 09/30/07 09/30/07 Outperform NS $18.56-3.77%-15.97%+12.20 Toggle the visibility of 60-Second Pitch and replies
TrackLeerinkSwan 98.64 05/21/07 05/21/07 Outperform NS $28.78-37.94%-15.97%-21.98
TrackJimCramer 81.15 02/05/07 02/05/07 Underperform 3W $26.89-33.58%-11.49%+22.09

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners